Man sent to jail for selling drugs in unlicensed premise

By Daudi Zirimala

The Makindye Grade One Magistrate Okumu Jude has sentenced a one Deo Mburakeye a resident of Masajja on Salama roads to 10 years imprisonment for the offenses of being in possession of classified drugs, selling drugs in unlicensed premises, unlawful possession of government drugs among others.

Speaking about the conviction of Mburakeye,the National Drug Authority NDA Head of Enforcement Samuel Kyomukama said that Muburakeye was among the 6 culprits arrested during the night operation that was conducted in Kampala and surrounding areas of Nalumunye,Kitemu,Salama,Kyanja,Rubaga and Nansana where 106 boxes of assorted medicines were impounded from five homes,and Mburakeye was found with 18 boxes of 91 impounded medicines labeled government of Uganda.

Kyomukama said that the conviction is a big land mark for NDA and a lesson to all those involved in stealing medicine from public health facilities which compromises the quality of health service delivery hence discrediting government programs.

Meanwhile National Drug Authority NDA through routine monitoring, surveillance and Intelligence on the quality of medical products on the market has discovered a substandard and falsified medicine, Augmentin, Postinor-2 and Quinine Bisulphate.

According to Lubowa Nasser the head of Post Market and Surveillance NDA,the surveillance was carried out in over 500 suspected drug outlets across the country and impounded the products from 14 drug outlets.

Lubowa noted that the drug outlets where the drugs were found and the suspect were arrested and investigations are on going,on the different particulars of Postinor-2 and Quinine.

WHO warns of new antibiotic resistant bacteria

The World Health Organization (WHO) has published it’s first-ever catalogue of antibiotic-resistant bacteria that pose the greatest threat to human health.

The list of priority pathogens consisting of 12 families of bacteria was drawn up as of the agency’s efforts to address growing global resistance to antimicrobial medicines.

The list highlights in particular the threat of gram-negative bacteria that are resistant to multiple antibiotics. These bacteria have built-in abilities to find new ways to resist treatment and can pass along genetic material that allows other bacteria to become drug-resistant as well.

A statement by the WHO shows that the most critical group of all includes multi-drug resistant bacteria that pose a particular threat in hospitals, nursing homes, and among patients whose care requires devices such as ventilators and blood catheters. They can cause severe and often deadly infections such as bloodstream infections and pneumonia.

These bacteria have become resistant to the best available antibiotics for treating multi-drug resistant bacteria.  The second and third tiers in the list contain other increasingly drug-resistant bacteria that cause more common diseases such as gonorrhea and food poisoning caused by salmonella.

“Antibiotic resistance is growing, and we are fast running out of treatment options. If we leave it to market forces alone, the new antibiotics we most urgently need are not going to be developed in time,” Dr Marie-Paule Kieny, WHO’s Assistant Director-General for Health Systems and Innovation, said.

The list is intended to spur governments to put in place policies that incentivize basic science and advanced research and development by both publicly funded agencies and the private sector investing in new antibiotic discovery.

WHO spokesperson Christian Lindmeier;

The list was developed in collaboration with the Division of Infectious Diseases at the University of Tübingen, Germany, using a multi-criteria decision analysis technique vetted by a group of international experts.

The criteria for selecting pathogens on the list were: how deadly the infections they cause are; whether their treatment requires long hospital stays; how frequently they are resistant to existing antibiotics when people in communities catch them; how easily they spread between animals, from animals to humans, and from person to person; whether they can be prevented, how many treatment options remain and whether new antibiotics to treat them are already in the pipeline.

Prof Evelina Tacconelli, the Head of the Division of Infectious Diseases at the University of Tübingen and a major contributor to the development of the list says that the new antibiotics targeting this priority list of pathogens will help to reduce deaths due to resistant infections around the world.

“Waiting any longer will cause further public health problems and dramatically impact on patient care,” she adds.

However, tuberculosis – whose resistance to traditional treatment has been growing in recent years – was not included in the list because it is targeted by other, dedicated programmes. Other bacteria that were not included, such as streptococcus A and B and chlamydia, have low levels of resistance to existing treatments and do not currently pose a significant public health threat, the statement adds.

The new hospital is short on medicine

By Alice Lubwama

Patients at newly established facility, Kirudu General Referral hospital in Makindye division are complaining about the shortage of drugs.

The hospital gets between 400-500 patients a day and it has only 32 medical doctors.

When a group of members of parliament led by the workers MP Margaret Rwabushaija visited the hospital to check on its state, several patients who were found on verandas, demanded that Government provide them with drugs instead of constructing building without medicine.

The patients say whenever they go to the hospital; they are always asked by the medical workers to go to nearby clinics to buy drugs.